Scientists have reconstructed the complete genome of a real person for the first time, including full sets of chromosomes from each parent, a breakthrough that is expected to accelerate genetic disease diagnosis and make personalized medicine routine in medical care. The achievement, led by Johns Hopkins University researchers and published today in Cell and Cell Genomics, fills critical gaps in our understanding of human genetics and demonstrates that complete, personalized genomes are now possible for anyone.

What Makes This Genome Breakthrough Different From Previous Efforts?

The Telomere-to-Telomere Consortium, or T2T, built on its 2022 completion of the first complete human genome by taking a much harder computational step. While the earlier work filled in the last 8% of a single genome, this new achievement reconstructs complete "diploid" genomes, meaning each genome contains two slightly different copies of every chromosome, with one copy inherited from each parent.

The team sequenced the HG002 human genome, a sample from a living donor widely used as a reference material by the DNA sequencing and diagnostics industries. With near-perfect accuracy, each chromosome now spans from "telomere to telomere" and reveals 15% more of the genome, including previously inaccessible portions relevant to cancer and neurological disorders. The team added more than 900 million DNA letters that were absent from prior benchmarks, including both sex chromosomes and areas with genes known to affect disease risk.

"The first T2T project was like assembling a huge jigsaw puzzle. This time, we had pieces from two similar puzzles, one from mom and one from dad, all thrown into the same box. So it's a harder computational challenge, but we've figured it out," said Adam Phillippy, a Johns Hopkins research professor of computer science, biomedical engineering, and genetic medicine.

Adam Phillippy, Research Professor of Computer Science, Biomedical Engineering, and Genetic Medicine at Johns Hopkins University

How Could This Technology Transform Medical Care?

The ability to quickly and affordably sequence a patient's entire genome is expected to dramatically improve the diagnosis of rare genetic diseases, especially in children. Currently, genetic analyses happen at lower accuracy, and in over half of cases, doctors may not be able to determine the genetic cause of a disease. Complete genomes could close this diagnostic gap and give families the answers they need.

The practical implications extend far beyond rare disease diagnosis. Doctors already use mutations of the BRCA1 and BRCA2 genes to predict the risk of breast cancer, but complete genomes could improve risk prediction for other cancers and complex traits such as heart disease, immune disorders, and neuropsychiatric conditions. Researchers expect to discover new genomic variants associated with known diseases and to train artificial intelligence-based models of the genome to more accurately diagnose rare genetic disease and inform personalized medical care.

Steps to Understanding How Personalized Genomics Will Work in Practice

• Complete Genome Sequencing at Birth: Individuals will have their entire genome sequence generated at birth and attached to their medical record, creating a unique genetic blueprint for their lifetime.
• Personalized Risk Assessment: Doctors will use complete genomes as their own unique reference for medical care, rather than comparing patients to a standard reference genome, ensuring no regions are missed and analysis quality does not depend on genetic similarity.
• AI-Powered Disease Prediction: Machine learning models trained on complete genomes from many individuals will help predict disease risk and inform precision medicine decisions throughout a patient's life.

What's the Cost Advantage of This New Approach?

The economic transformation is staggering. The total cost of the Human Genome Project, which concluded in 2003, was about $5 billion in today's dollars. A more complete and accurate result can now be had for about $5,000, representing a million-fold reduction in cost. This dramatic decrease in price makes widespread adoption of personalized genomics feasible for healthcare systems worldwide.

"It will soon become commonplace to sequence an individual's entire genome. What will that enable? And what does the future of medicine look like when you can generate someone's complete genome at birth, attach it to their medical record, and then use that to inform precision medicine throughout their life? Complete, personalized genomes are now possible for anyone," explained Adam Phillippy.

Adam Phillippy, Research Professor of Computer Science, Biomedical Engineering, and Genetic Medicine at Johns Hopkins University

How Did Researchers Validate This Complex Achievement?

The work involved collaboration across multiple institutions and expertise areas. At Johns Hopkins, computational biologist Steven Salzberg and his team, including PhD student Hyun Joo "Hayden" Ji, led the effort to identify all of the genes on each chromosome copy. Computational biologist Michael Schatz's lab participated in what Phillippy called a "crowdsourcing" effort to extensively validate the accuracy of the work. The National Institute of Standards and Technology (NIST) contributed critical standardization expertise, with NIST scientist Justin Zook noting that the achievement gives technology developers the standard they need to measure and improve accuracy across the most complex regions of the human genome.

The work is published today as part of a 12-paper package of genomic advances in Cell and Cell Genomics, including papers that feature genome sequencing and analysis for eight additional vertebrate species including macaque, marmoset, and zebra finch. The ability of this technology to reconstruct the complete or near-complete genome of any vertebrate species is highlighted by companion papers featuring rat, vole, horse, donkey, and giraffe. These animal reference genomes are enabling research in evolution, biodiversity, and agriculture, such as how primates evolved, how birds learn to sing, and how livestock digest vegetation.

This represents a paradigm shift in genomic medicine. Rather than trying to find the differences between a patient's genome and a reference standard, researchers can now reconstruct each person's complete, unique genome. This ensures that no regions of the genome are missed and that the quality of analysis does not depend on how similar a patient is to the reference genome, fundamentally changing how precision medicine will be practiced in the future.